Pfizer
BSE: 500680 | NSE: PFIZER | ISIN: INE182A01018 | Pharmaceuticals
 |
Balance Sheet of Pfizer |
------------------- in Rs. Cr. ------------------- |
| Nov '04 | Nov '05 | Nov '06 | Nov '07 | Nov '08 | ||||||
|
||||||||||
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||||||
|
||||||||||
| Sources Of Funds | ||||||||||
| Total Share Capital | 28.80 | 29.84 | 29.84 | 29.84 | 29.84 | |||||
| Equity Share Capital | 28.80 | 29.84 | 29.84 | 29.84 | 29.84 | |||||
| Share Application Money | 1.04 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Preference Share Capital | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Reserves | 312.92 | 346.72 | 409.91 | 618.80 | 869.72 | |||||
| Revaluation Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Networth | 342.76 | 376.56 | 439.75 | 648.64 | 899.56 | |||||
| Secured Loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Unsecured Loans | 12.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Total Debt | 12.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Total Liabilities | 354.76 | 376.56 | 439.75 | 648.64 | 899.56 | |||||
| Nov '04 | Nov '05 | Nov '06 | Nov '07 | Nov '08 | ||||||
|
||||||||||
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||||||
|
||||||||||
| Application Of Funds | ||||||||||
| Gross Block | 158.77 | 170.15 | 168.14 | 141.61 | 139.90 | |||||
| Less: Accum. Depreciation | 87.06 | 94.59 | 98.19 | 81.45 | 89.14 | |||||
| Net Block | 71.71 | 75.56 | 69.95 | 60.16 | 50.76 | |||||
| Capital Work in Progress | 3.94 | 2.14 | 1.60 | 10.24 | 32.30 | |||||
| Investments | 3.24 | 3.32 | 3.32 | 3.82 | 3.82 | |||||
| Inventories | 73.89 | 89.83 | 98.45 | 95.06 | 124.68 | |||||
| Sundry Debtors | 71.73 | 82.82 | 69.63 | 61.37 | 59.73 | |||||
| Cash and Bank Balance | 8.01 | 8.31 | 12.02 | 18.85 | 22.99 | |||||
| Total Current Assets | 153.63 | 180.96 | 180.10 | 175.28 | 207.40 | |||||
| Loans and Advances | 83.18 | 83.24 | 88.64 | 161.03 | 1,014.84 | |||||
| Fixed Deposits | 153.09 | 201.62 | 294.48 | 460.94 | 520.07 | |||||
| Total CA, Loans & Advances | 389.90 | 465.82 | 563.22 | 797.25 | 1,742.31 | |||||
| Deffered Credit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Current Liabilities | 119.90 | 139.19 | 147.07 | 110.78 | 125.15 | |||||
| Provisions | 54.21 | 67.80 | 64.60 | 114.97 | 804.46 | |||||
| Total CL & Provisions | 174.11 | 206.99 | 211.67 | 225.75 | 929.61 | |||||
| Net Current Assets | 215.79 | 258.83 | 351.55 | 571.50 | 812.70 | |||||
| Miscellaneous Expenses | 60.07 | 36.70 | 13.34 | 2.93 | 0.00 | |||||
| Total Assets | 354.75 | 376.55 | 439.76 | 648.65 | 899.58 | |||||
|
||||||||||
| Contingent Liabilities | 52.53 | 54.30 | 78.64 | 124.25 | 87.10 | |||||
| Book Value (Rs) | 118.66 | 126.19 | 147.36 | 217.36 | 301.45 | |||||
| ||||||||||
| Source : Religare Technova | ||||||||||
| Explore Pfizer connections | ||||||||||
| ||||||||||
